We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
ARX-TELMISARTAN/AMLODIPINE (Alembic Pharmaceuticals Australia Pty Ltd)
Product name
ARX-TELMISARTAN/AMLODIPINE
Date registered
Evaluation commenced
Decision date
Approval time
128 (255 working days)
Active ingredients
amlodipine besilate, telmisartan
Registration type
New generic medicine
Indication
Treatment of hypertension. Treatment should not be initiated with this fixed-dose combination.